Stock Screens 

Eight high-octane small-caps

Eight high-octane small-caps

Hang onto your hat. It’s time to revisit the Small Caps on Steroids stock screen. This is only the third year I’ve run this high-risk, convention-flouting screen, but already it’s been a white-knuckle ride. After delivering outstanding returns on its first outing, last year’s picks looked as though they would repeat the trick until lockdown prompted a vertiginous plunge. That said, the screen still shows noteworthy outperformance of the index over the two years as a whole. The screen has come up with eight high-risk high-reward plays for the coming 12 months.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now